Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C014024 |
2,4,5,2',4',5'-hexachlorobiphenyl |
2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of SREBF2 mRNA | decreases expression | 20005886
|
C007997 |
25-hydroxycholesterol |
25-hydroxycholesterol results in decreased activity of SREBF2 protein | decreases activity | 17052361
|
C007997 |
25-hydroxycholesterol |
Clozapine inhibits the reaction [25-hydroxycholesterol results in decreased activity of SREBF2 protein] | decreases activity|decreases reaction | 17052361
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of SREBF2 mRNA | affects expression | 21346803
|
C065250 |
4-hydroxy-equilenin |
4-hydroxy-equilenin results in decreased expression of SREBF2 mRNA | decreases expression | 15135645
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in increased expression of SREBF2 mRNA | increases expression | 16541421
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in increased expression of SREBF2 mRNA | increases expression | 16990341
|
D000639 |
Amitriptyline |
Amitriptyline results in increased cleavage of and results in increased activity of SREBF2 protein | increases activity|increases cleavage | 16324787
|
C065179 |
atorvastatin |
atorvastatin results in increased expression of SREBF2 mRNA | increases expression | 12065722
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of SREBF2 mRNA | decreases expression | 20106945
|
D001629 |
Bezafibrate |
Bezafibrate results in increased expression of SREBF2 mRNA | increases expression | 14685799
|
D002104 |
Cadmium |
Cadmium results in increased expression of SREBF2 mRNA | increases expression | 17066326
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in increased expression of SREBF2 mRNA | increases expression | 17066326
|
D002746 |
Chlorpromazine |
Chlorpromazine results in increased cleavage of and results in increased activity of SREBF2 protein | increases activity|increases cleavage | 17052361
|
D002791 |
Cholesterol, Dietary |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of SREBF2 mRNA | affects cotreatment|decreases expression | 19509184
|
D015283 |
Citalopram |
Citalopram results in increased cleavage of and results in increased activity of SREBF2 protein | increases activity|increases cleavage | 16324787
|
D002997 |
Clomipramine |
Clomipramine results in increased cleavage of and results in increased activity of SREBF2 protein | increases activity|increases cleavage | 16324787
|
D003024 |
Clozapine |
Clozapine inhibits the reaction [25-hydroxycholesterol results in decreased activity of SREBF2 protein] | decreases activity|decreases reaction | 17052361
|
D003024 |
Clozapine |
Clozapine results in increased cleavage of and results in increased activity of SREBF2 protein | increases activity|increases cleavage | 17052361
|
D003024 |
Clozapine |
Clozapine results in increased expression of SREBF2 mRNA | increases expression | 17052361
|
C012258 |
compactin |
compactin results in increased expression of SREBF2 protein | increases expression | 17526932
|
D004041 |
Dietary Fats |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of SREBF2 mRNA | affects cotreatment|decreases expression | 19509184
|
C108606 |
ezetimibe |
ezetimibe results in decreased expression of SREBF2 mRNA | decreases expression | 16177187
|
D011345 |
Fenofibrate |
Fenofibrate results in increased expression of SREBF2 mRNA | increases expression | 14685799
|
D005632 |
Fructose |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of SREBF2 mRNA | affects cotreatment|decreases expression | 19509184
|
D015248 |
Gemfibrozil |
Gemfibrozil results in increased expression of SREBF2 mRNA | increases expression | 14685799
|
C442817 |
GW 707 |
Oncostatin M promotes the reaction [GW 707 affects the localization of SREBF2 protein] | affects localization|increases reaction | 12524230
|
D006220 |
Haloperidol |
Haloperidol results in increased cleavage of and results in increased activity of SREBF2 protein | increases activity|increases cleavage | 17052361
|
D006861 |
Hydrogen Peroxide |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased cleavage of and results in increased activity of SREBF2 protein | affects cotreatment|increases activity|increases cleavage | 18032389
|
D006861 |
Hydrogen Peroxide |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SREBF2 mRNA | affects cotreatment|increases expression | 18032389
|
D006861 |
Hydrogen Peroxide |
SREBF2 protein affects the susceptibility to [isoquercitrin co-treated with Hydrogen Peroxide] | affects cotreatment|affects response to substance | 18032389
|
D007099 |
Imipramine |
Imipramine results in increased cleavage of and results in increased activity of SREBF2 protein | increases activity|increases cleavage | 16324787
|
C016527 |
isoquercitrin |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased cleavage of and results in increased activity of SREBF2 protein | affects cotreatment|increases activity|increases cleavage | 18032389
|
C016527 |
isoquercitrin |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SREBF2 mRNA | affects cotreatment|increases expression | 18032389
|
C016527 |
isoquercitrin |
SREBF2 protein affects the susceptibility to [isoquercitrin co-treated with Hydrogen Peroxide] | affects cotreatment|affects response to substance | 18032389
|
D008798 |
Mevalonic Acid |
Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [SREBF2 protein binds to PON1 promoter]] | affects binding|decreases reaction|increases reaction | 14500290
|
C076029 |
olanzapine |
olanzapine results in increased cleavage of and results in increased activity of SREBF2 protein | increases activity|increases cleavage | 17052361
|
D053683 |
Oncostatin M |
Oncostatin M promotes the reaction [GW 707 affects the localization of SREBF2 protein] | affects localization|increases reaction | 12524230
|
D012643 |
Selenium |
Selenium results in increased expression of SREBF2 mRNA | increases expression | 19244175
|
D019821 |
Simvastatin |
Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [SREBF2 protein binds to PON1 promoter]] | affects binding|decreases reaction|increases reaction | 14500290
|
D019821 |
Simvastatin |
Simvastatin promotes the reaction [SREBF2 protein binds to PON1 promoter] | affects binding|increases reaction | 14500290
|
C025462 |
sulindac sulfide |
sulindac sulfide results in decreased expression of SREBF2 mRNA | decreases expression | 16184548
|
D013739 |
Testosterone |
Testosterone results in increased expression of SREBF2 mRNA | increases expression | 16579987
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SREBF2 mRNA | decreases expression | 20005886
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.50 | 14514962 15322242 11752688 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.90 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.45 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.71 | 12649775 14617031 16160616 |
MESH:D000544 |
Alzheimer Disease |
|
Cholesterol, Dietary |
4.79 | 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
4.79 | 18759972 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.64 | 11748828 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.49 | 7506515 |
MESH:D001008 |
Anxiety Disorders |
|
Citalopram |
5.14 | 18083778 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.73 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cholesterol, Dietary |
9.54 | 15552841 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
9.54 | 15238619 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.43 | 15687053 |
MESH:D001321 |
Autistic Disorder |
|
Citalopram |
2.65 | 18775368 19232924 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.65 | 19368416 18080171 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
2.65 | 18685284 17069543 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.73 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.43 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.54 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.92 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.92 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
1.92 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.52 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.72 | 16705839 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.32 | 12391285 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
1.95 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
atorvastatin |
6.55 | 18360054 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.55 | 16120746 18850075 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.27 | 16936243 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.56 | 1977408 15215559 |
MESH:D002386 |
Cataract |
|
Simvastatin |
4.42 | 12518039 |
MESH:D002389 |
Catatonia |
|
olanzapine |
5.89 | 16772815 18071103 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.20 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
6.20 | 17332340 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Citalopram |
6.49 | 15782081 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
6.49 | 20678186 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.87 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.95 | 15668235 15340226 16354765 12621046 8697196 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.62 | 17123785 |
MESH:D003092 |
Colitis |
|
Selenium |
3.44 | 17936198 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.76 | 17141729 14669216 |
MESH:D003324 |
Coronary Artery Disease |
|
atorvastatin |
4.01 | 16368305 |
MESH:D003327 |
Coronary Disease |
|
Fructose |
4.25 | 18504504 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.24 | 15322242 10048152 20055451 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.67 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Simvastatin |
4.64 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.52 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.26 | 11575062 |
MESH:D003866 |
Depressive Disorder |
|
Amitriptyline |
16.59 | 15014590 18083778 |
MESH:D003866 |
Depressive Disorder |
|
Citalopram |
16.59 | 15014590 |
MESH:D003866 |
Depressive Disorder |
|
Clomipramine |
16.59 | 18083778 |
MESH:D003866 |
Depressive Disorder |
|
Imipramine |
16.59 | 20305041 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.45 | 17069543 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
4.21 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
6.76 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
6.76 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.76 | 17107852 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.19 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.10 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorpromazine |
8.10 | 11461765 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
8.10 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.10 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.50 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
18.70 | 16402076 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
18.70 | 18367378 |
MESH:D050171 |
Dyslipidemias |
|
Fenofibrate |
18.70 | 16707586 |
MESH:D050171 |
Dyslipidemias |
|
Gemfibrozil |
18.70 | 16707586 |
MESH:D004487 |
Edema |
|
Amitriptyline |
14.12 | 12798668 |
MESH:D004487 |
Edema |
|
Clomipramine |
14.12 | 12798668 |
MESH:D004487 |
Edema |
|
Imipramine |
14.12 | 12798668 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
14.12 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.54 | 18230668 15322242 16714409 |
MESH:D016889 |
Endometrial Neoplasms |
|
Fenofibrate |
3.86 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.72 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.92 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.75 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
7.25 | 19551842 17967931 19004024 18296743 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
7.25 | 18641190 18395287 19196556 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.11 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
12.92 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Fructose |
12.92 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.92 | 20067830 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.49 | 7506515 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
3.82 | 17162496 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
5.00 | 19165636 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.23 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.81 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.81 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
atorvastatin |
6.94 | 16360360 |
MESH:D006333 |
Heart Failure |
|
Selenium |
6.94 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.02 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.55 | 12621046 15340226 16120746 |
MESH:D006561 |
Herpes Simplex |
|
Chlorpromazine |
4.94 | 1682908 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
5.29 | 17019078 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.68 | 8697196 18606429 16959395 15340226 16354765 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.95 | 17019078 |
MESH:D006937 |
Hypercholesterolemia |
|
atorvastatin |
19.44 | 11583720 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol, Dietary |
19.44 | 10876104 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
19.44 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
ezetimibe |
19.44 | 17076980 15374793 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.61 | 18563319 18360027 19008412 14757778 15752949 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.56 | 16046005 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
8.47 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
8.47 | 15752949 |
MESH:D006938 |
Hyperlipoproteinemia Type II |
|
atorvastatin |
9.53 | 16238680 |
MESH:D006938 |
Hyperlipoproteinemia Type II |
|
Simvastatin |
9.53 | 16238680 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
5.87 | 17933447 |
MESH:D006973 |
Hypertension |
|
atorvastatin |
8.10 | 17042910 |
MESH:D006973 |
Hypertension |
|
Fructose |
8.10 | 14568997 16843071 19008412 14573337 14633139 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.10 | 18850075 18670907 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.77 | 19342510 19799862 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.34 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.84 | 17426086 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.49 | 7506515 |
MESH:D007249 |
Inflammation |
|
Amitriptyline |
17.54 | 12798668 |
MESH:D007249 |
Inflammation |
|
atorvastatin |
17.54 | 16908763 |
MESH:D007249 |
Inflammation |
|
Clomipramine |
17.54 | 12798668 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
17.54 | 20412841 |
MESH:D007249 |
Inflammation |
|
Imipramine |
17.54 | 12798668 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
17.54 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
3.84 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.07 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
7.07 | 19586609 18981581 14573337 14757778 18057795 19342510 18563319 19799862 14633139 19008412 17133782 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
6.00 | 16322080 16226777 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
6.00 | 16962696 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
8.98 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
8.98 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
2.70 | 16705839 |
MESH:D008064 |
Lipidoses |
|
Amitriptyline |
27.35 | 15342952 17567588 |
MESH:D008064 |
Lipidoses |
|
Chlorpromazine |
27.35 | 15342952 17567588 |
MESH:D008064 |
Lipidoses |
|
Citalopram |
27.35 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Clomipramine |
27.35 | 15342952 17567588 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
27.35 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Imipramine |
27.35 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.68 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
atorvastatin |
3.53 | 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Fenofibrate |
3.53 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.53 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Chlorpromazine |
3.59 | 14986274 |
MESH:D008113 |
Liver Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
12.75 | 18644402 16835634 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
12.75 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
12.75 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Fenofibrate |
12.75 | 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
12.75 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
8.63 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Fenofibrate |
8.63 | 18775883 18253720 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
8.63 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
4.46 | 20210726 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.07 | 17053015 20135361 20464547 18520028 20869020 6695378 20064080 18816296 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.07 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.54 | 15318939 |
MESH:D001523 |
Mental Disorders |
|
Amitriptyline |
36.76 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Chlorpromazine |
36.76 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Citalopram |
36.76 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Clomipramine |
36.76 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
36.76 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
36.76 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Imipramine |
36.76 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
36.76 | 16856516 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.65 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.07 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
9.09 | 19142101 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
9.09 | 17261469 17098227 18497449 16815490 19165636 |
MESH:D008881 |
Migraine Disorders |
|
Amitriptyline |
4.54 | 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.92 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
atorvastatin |
16.24 | 16239165 |
MESH:D009135 |
Muscular Diseases |
|
Bezafibrate |
16.24 | 16239165 |
MESH:D009135 |
Muscular Diseases |
|
Gemfibrozil |
16.24 | 16239165 |
MESH:D009175 |
Mycoplasma Infections |
|
Chlorpromazine |
5.64 | 10773494 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.74 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.51 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
4.86 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.86 | 11141357 |
MESH:D009404 |
Nephrotic Syndrome |
|
atorvastatin |
4.86 | 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
2.88 | 14600291 |
MESH:D009765 |
Obesity |
|
Clozapine |
10.00 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
10.00 | 20132043 20518802 18674790 17217161 19632207 21332399 11836018 18457598 16723640 |
MESH:D009765 |
Obesity |
|
Fructose |
10.00 | 18585860 17707055 |
MESH:D009765 |
Obesity |
|
olanzapine |
10.00 | 18515891 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.13 | 16049721 |
MESH:D010146 |
Pain |
|
Amitriptyline |
10.33 | 12798668 |
MESH:D010146 |
Pain |
|
Clomipramine |
10.33 | 12798668 |
MESH:D010146 |
Pain |
|
Imipramine |
10.33 | 12798668 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.74 | 12065085 |
MESH:D010300 |
Parkinson Disease |
|
Cholesterol, Dietary |
4.04 | 19014385 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.89 | 12520081 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.03 | 15687053 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.53 | 15087411 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Simvastatin |
5.03 | 17105841 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.22 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.84 | 11896295 11399792 11118676 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
4.74 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.58 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
3.58 | 17075824 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
10.66 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
10.66 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
8.31 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
8.31 | 11575062 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.50 | 18990726 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
5.53 | 20521320 20107430 11151749 18855531 19369910 20168265 20452607 20580759 17123785 16141801 20521326 17667964 11763009 17726453 18806925 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
5.53 | 18513383 1830565 20107430 19369910 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
5.53 | 20107430 20521326 17726453 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.31 | 18551238 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.84 | 16631401 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
8.44 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
8.44 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.44 | 16192470 |
MESH:D012892 |
Sleep Deprivation |
|
Imipramine |
5.84 | 19798453 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Amitriptyline |
5.09 | 15341891 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.55 | 20155912 2093021 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
9.84 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
9.84 | 20210726 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.54 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
4.49 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
4.49 | 17053015 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.96 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
4.32 | 18645019 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.23 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.89 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
14.71 | 17502770 20521320 20564506 16402076 16141801 20107430 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
14.71 | 16723640 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
14.71 | 17933447 20107430 19434072 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.72 | 17933447 |